Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05408533 · ClinicalTrials.gov registry record · NA
Silver-Coated vs Standard Catheter for UTI Prevention
A NA study, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT05408533 is a NA study that has completed, run by TriHealth. The registered enrollment target is 310 participants.
The verdict
NCT05408533, a NA study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
Primary Aim: To determine whether silver-coated transurethral catheter decreases the incidence of culture-confirmed urinary tract infection for women with catheter-managed urinary retention after pelvic reconstructive surgery Secondary Aims: To assess difference in bacterial uropathogens isolated in urine cultures Adverse symptoms possibly caused by silver-coated catheter
Interventions
- DEVICE 2-Way Foley Urethral Urinary Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2022-06-14 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05408533
The ClinicalTrials.gov registry entry for NCT05408533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2-Way Foley Urethral Urinary Catheter is the first listed.
NCT05408533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05408533 about?
NCT05408533 is a clinical study titled "Silver-Coated vs Standard Catheter for UTI Prevention". Primary Aim: To determine whether silver-coated transurethral catheter decreases the incidence of culture-confirmed urinary tract infection for women with catheter-managed urinary retention after pelvic reconstructive surgery Secondary Aims: To assess difference in bacterial uropathogens isolated ...
What is the current status of trial NCT05408533?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2022-06-14. Estimated completion is 2024-05-01.
What interventions are being tested in trial NCT05408533?
The interventions under investigation include: 2-Way Foley Urethral Urinary Catheter (DEVICE).
Who is sponsoring clinical trial NCT05408533?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.